Louie Rayal, PhD

Louie is an Enterprise Technology, AI, Risk, and Governance executive with more than 20 years of leadership experience across the global life sciences industry. He has led large-scale transformations spanning regulatory compliance, digital quality, enterprise risk management, cybersecurity, and the compliant adoption of AI at scale. As Vice President of Governance, Risk & Compliance within GSK’s Global Digital & Technology organization, Louie has led the transformation of the technology governance and risk management framework, and championed the use of automation, advanced analytics, and AI-enabled GRC capabilities to move governance and compliance from traditional, manually intensive approaches toward more proactive, risk-based, and data-driven models. Prior to GSK, Louie held senior leadership positions at Abbott and Takeda, where he led global organizations responsible for IT quality, regulatory compliance, computer system validation, and technology transformation. His experience includes managing complex global technology environments across regulated GxP operations and developing enterprise approaches aligned with FDA requirements, Computer Software Assurance (CSA), EMA Annex 11, SOX, and other global regulatory expectations. Louie is an active contributor to the broader life sciences and technology community. He contributed to the ISPE GAMP® Good Practice Guide: Testing GxP Systems, Third Edition, supporting the evolution of risk-based testing, Computer Software Assurance, modern development practices, and right-sized validation approaches. He is also a member of FICSA (FDA Industry Computer Software Assurance) and other industry forums focused on advancing modern software assurance practices. Louie holds a Bachelor of Science in Biochemistry from the University of Illinois Chicago and an MBA from Lake Forest Graduate School of Management. He also holds professional credentials including ISC2 CGRC, PMP, CQA, and CMSQ.